Ventricular restraint therapy for heart failure: A review, summary of state of the art, and future directions

Journal of Thoracic and Cardiovascular Surgery

Volumn 144, Issue 4, 2012, Pages 771-777.e1

  Kwon, Michael H ^a   Cevasco, Marisa ^a   Schmitto, Jan D ^a   Chen, Frederick Y ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL;

CARDIOMYOPLASTY; CARDIOVASCULAR PARAMETERS; CLINICAL TRIAL (TOPIC); DEVICE SAFETY; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; NONHUMAN; PEER REVIEW; PRIORITY JOURNAL; QUANTITATIVE VENTRICULAR RESTRAINT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THERAPY; TRANSVENTRICULAR GIRDLE DEVICE; VENTRICULAR RESTRAINT DEVICE; VENTRICULAR RESTRAINT THERAPY;

EID: 84866373026     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2012.06.014     Document Type: Editorial

References (55)

1. D.M. Lloyd-Jones, R. Adams, M. Carnethon, J. De Simone, T.B. Ferguson, and K. Flegal Heart Disease and Stroke Statistics - 2009 update. A report from the American Heart Association statistics committee and stroke statistics subcommittee Circulation 119 2009 480 486
2. D.A. Kass, K.L. Baughman, P.H. Pak, P.W. Cho, H.R. Levin, and T.J. Gardner Reverse remodeling from cardiomyoplasty in human heart failure: external constraint versus active assist Circulation 91 1995 2314 2318
3. E.R. Capouya, R.S. Gerber, D.C. Drinkwater Jr., J.M. Pearl, J.B. Sack, and A.S. Aharon Girdling effect of nonstimulated cardiomyoplasty on left ventricular function Ann Thorac Surg 56 1993 867 871
4. J.M. Power, J. Raman, A. Dornom, S.J. Farish, L.M. Burrell, and A.M. Tonkin Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy Cardiovasc Res 44 1999 549 555
5. J.A. Magovern, L. Teekell-Taylor, S. Mankad, U. Dasika, W. McGregor, and R.W. Biederman Effect of a flexible ventricular restraint device on cardiac remodeling after acute myocardial infarction ASAIO J 52 2006 196 200
6. R.K. Ghanta, A. Rangaraj, R. Umakanthan, L. Lee, R.G. Laurence, and J.A. Fox Adjustable, physiological ventricular restraint improves left ventricular mechanics and reduces dilatation in an ovine model of chronic heart failure Circulation 115 2007 1201 1210
7. M.C. Oz Surgical implantation of the Acorn cardiac support device Op Tech Thorac Cardiovasc Surg 7 2002 107 110
8. S.T. Kelley, R. Malekan, J.H. Gorman III, B.M. Jackson, R.C. Gorman, and Y. Suzuki Restraining infarct expansion preserves left ventricular geometry and function after acute antero-apical infarction Circulation 99 1999 135 142
9. A. Cheng, T.C. Nguyen, M. Malinowski, F. Langer, D. Liang, and G.T. Daughters Passive ventricular constraint prevents transmural shear strain progression in left ventricle remodelling Circulation 114 1 Suppl 2006 I79 I86
10. P.A. Chaudhry, T. Mishima, V.G. Sharov, J. Hawkins, C. Alferness, and G. Paone Passive epicardial containment prevents ventricular remodeling in heart failure Ann Thorac Surg 70 2000 1275 1280
11. P.A. Chaudhry, P.V. Anagostopouls, T. Mishima, G. Suzuki, H. Nair, and H. Morita Acute ventricular reduction with the Acorn cardiac support device: effect on progressive left ventricular dysfunction and dilation in dogs with chronic heart failure J Card Surg 16 2001 118 126
12. H.N. Sabbah, V.G. Sharov, P.A. Chaudhry, G. Suzuki, A. Todor, and H. Morita Chronic therapy with the Acorn cardiac support device in dogs with chronic heart failure: three and six months hemodynamic, histologic and ultrastructural findings J Heart Lung Transplant 20 2001 189
13. J.J. Pilla, A.S. Blom, D.J. Brockman, V.A. Ferrari, Q. Yuan, and M.A. Acker Passive ventricular constraint to improve left ventricular function and mechanics in an ovine model of heart failure secondary to acute myocardial infarction J Thorac Cardiovasc Surg 126 2003 1467 1476
14. Y. Enomoto, J.H. Gorman III, S.L. Moainie, B.M. Jackson, L.M. Parish, and T. Plappert Early ventricular restraint after myocardial infarction: extent of the wrap determines the outcome of remodeling Ann Thorac Surg 79 2005 881 887
15. A.S. Blom, R. Mukherjee, J.J. Pilla, A.S. Lowry, W.M. Yarbrough, and J.T. Mingoia Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction Circulation 112 2005 1274 1283
16. A.S. Blom, J.J. Pilla, J. Arkles, L. Dougherty, L.P. Ryan, and J.H. Gorman III Ventricular restraint prevents infarct expansion and improves borderzone function after myocardial infarction: a study using magnetic resonance imaging, three-dimensional surface modeling, and myocardial tagging Ann Thorac Surg 84 2007 2004 2010
17. J.J. Pilla, A.S. Blom, J.H. Gorman III, D.J. Brockman, J. Affuso, and L.M. Parish Early postinfarction ventricular restraint improves borderzone wall thickening dynamics during remodeling Ann Thorac Surg 80 2005 2257 2262
18. S.L. Moainie, T.S. Guy, J.H. Gorman III, T. Plappert, B.M. Jackson, and M.G. John-Sutton Infarct restraint attenuates remodeling and reduces chronic ischemic mitral regurgitation after postero-lateral infarction Ann Thorac Surg 74 2002 444 449
19. M.C. Oz, W.F. Konertz, F.X. Kleber, F.W. Mohr, J.F. Gummert, and J. Ostermeyer Global surgical experience with the Acorn cardiac support device J Thorac Cardiovasc Surg 126 2003 983 991
20. R.C. Starling, and M. Jessup Worldwide clinical experience with the CorCap cardiac support device J Card Fail 10 2004 S225 S233
21. D.L. Mann, M.A. Acker, M. Jessup, H.N. Sabbah, R.C. Starling, and S.H. Kubo Rationale, design, and methods for a pivotal randomized clinical trial for the assessment of a cardiac support device in patients with New York health association class III-IV heart failure J Card Fail 10 2004 185 192
22. M.A. Acker, S. Bolling, R. Shemin, J. Kirklin, J.K. Oh, and D.L. Mann Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial J Thorac Cardiovasc Surg 132 2006 568 577 577.e1-4
23. D.L. Mann, M.A. Acker, M. Jessup, H.N. Sabbah, R.C. Starling, and S.H. Kubo Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy Ann Thorac Surg 84 2007 1226 1235
24. R.C. Starling, M. Jessup, J.K. Oh, H.N. Sabbah, M.A. Acker, and D.L. Mann Sustained benefits of the Corcap cardiac support device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial Ann Thorac Surg 84 2007 1236 1242
25. D.L. Mann, S.H. Kubo, H.N. Sabbah, R.C. Starling, M. Jessup, and J.K. Oh Beneficial effects of the CorCap cardiac support device: five-year results from the Acorn Trial J Thorac Cardiovasc Surg 143 2012 1036 1042
26. M.A. Acker, M. Jessup, S.F. Bolling, J. Oh, R.C. Starling, and D.L. Mann Mitral valve repair in heart failure: five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial Cardiovasc Surg 142 2011 569 574
27. C.T. Klodell Jr., D.C. McGiffin, B.K. Rayburn, B. Sun, W.T. Abraham, and J.V. Conte Initial United States experience with the Paracor HeartNet myocardial constraint device for heart failure J Thorac Cardiovasc Surg 133 2007 204 209
28. C.T. Klodell Jr., J.M. Aranda Jr., D.C. McGiffin, B.K. Rayburn, B. Sun, and W.T. Abraham Worldwide surgical experience with the Paracor HeartNet cardiac restraint device J Thorac Cardiovasc Surg 135 2008 188 195
29. Abraham WT. Ventricular elastic support therapy (VEST) in stage C heart failure: analysis from the PEERLESS-HF study. Heart Failure Society of America 2010 Scientific Meeting, September 13, 2010, San Diego, CA. Late-breaking clinical trial 1.
30. R.K. Ghanta, L.S. Lee, R. Umakanthan, R.G. Laurence, J.A. Fox, and R.M. Bolman III Real-time adjustment of ventricular restraint therapy in heart failure Eur J Cardiothorac Surg 34 2008 1136 1140
31. Lee LS, Ghanta RK, Mokashi SA, Coelho-Filho O, Kwong RY, Kwon M, et al. Optimized ventricular restraint therapy: adjustable restraint is superior to standard restraint in ischemic cardiomyopathy. J Thorac Cardiovasc Surg. June 12, 2012 [epub ahead of print].
32. L.S. Lee, R.K. Ghanta, S.A. Mokashi, O. Coelho-Filho, R.Y. Kwong, and R.M. Bolman III Ventricular restraint therapy for heart failure: the right ventricle is different than the left ventricle J Thorac Cardiovasc Surg 139 2010 1012 1018
33. R.H. Jones, E.J. Velazquez, R.E. Michler, G. Sopko, J.K. Oh, and C.M. O'Connor Coronary bypass surgery with or without surgical ventricular reconstruction N Engl J Med 360 2009 1705 1717
34. A. Franco-Cereceda, P.M. McCarthy, E.H. Blackstone, K.J. Hoercher, J.A. White, and J.B. Young Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation? J Thorac Cardiovasc Surg 121 2001 879 893
35. D.B. Mark, J.D. Knight, E.J. Velazquez, J.G. Howlett, J.A. Spertus, and L.T. Djokovic Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial Am Heart J 157 2009 837 844 844.e1-3
36. M.W. Weston, R. Vijayangar, R.M. Overton, and D.L. Veseley Prospective evaluation of the Batista procedure with circulating atrial natriuretic peptides Int J Cardiol 74 2000 145 152
37. P.M. McCarthy, M. Takagaki, Y. Ochiai, J.B. Young, T. Tabata, and T. Shiota Device-based change in left ventricular shape: a new concept for the treatment of dilated cardiomyopathy J Thorac Cardiovasc Surg 122 2001 482 490
38. M.S. Slaughter, A.L. Meyer, and E.J. Birks Destination therapy with left ventricular assist devices: patient selection and outcomes Curr Opin Cardiol 26 2011 232 256
39. S. Aggarwal, and F.D. Pagani Bridge to transplantation: current outcomes J Card Surg 25 2010 455 461
40. R. John, K. Liao, K. Lietz, F. Kamdar, M. Colvin-Adams, and A. Boyle Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure J Thorac Cardiovasc Surg 134 2007 351 358
41. E.J. Birks, P.D. Tansley, J. Hardy, R.S. George, C.T. Bowles, and M. Burke Left ventricular assist device and drug therapy for the reversal of heart failure N Engl J Med 355 2006 1873 1884
42. M.P. Anstadt, S. Budharaju, R.J. Darner, B.A. Schmitt, L.J. Prochaska, and A.J. Pothoulakis Ventricular actuation improves systolic and diastolic myocardial function in the small failing heart Ann Thorac Surg 88 2009 1982 1988
43. J.C. Chachques, O. Jegaden, T. Mesana, Y. Glock, P.A. Grandjean, and A.F. Carpentier Cardiac bioassist: results of the French multicenter cardiomyoplasty study Asian Cardiovasc Thorac Ann 17 2009 573 580
44. V. Zacà, R. Brewer, S. Khanal, M. Imai, A. Jiang, and M. Wang Left atrial reverse remodeling in dogs with moderate and advanced heart failure treated with a passive mechanical containment device: an echocardiographic study J Card Fail 13 2007 312 317
45. H.N. Sabbah, V.G. Sharov, R.C. Gupta, S. Mishra, and S. Rastogi Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment Circ Res 93 2003 1095 1101 Epub 2003 Oct 16
46. H.N. Sabbah Effects of cardiac support device on reverse remodeling: molecular, biochemical, and structural mechanisms J Card Fail 10 6 Suppl 2004 S207 S214
47. R.C. Gupta, S. Mishra, S. Rastogi, V.G. Sharov, and H.N. Sabbah Improvement of cardiac sarcoplasmic reticulum calcium cycling in dogs with heart failure following long-term therapy with the Acorn Cardiac Support Device Heart Fail Rev 10 2005 149 155
48. S. Rastogi, S. Mishra, R.C. Gupta, and H.N. Sabbah Reversal of maladaptive gene program in left ventricular myocardium of dogs with heart failure following long-term therapy with the Acorn Cardiac Support Device Heart Fail Rev 10 2005 157 163
49. F.W. Bowen, S.C. Jones, N. Narula, M.G. St. John Sutton, T. Plappert, and L.H. Edmunds Jr. Restraining acute infarct expansion decreases collagenase activity in borderzone myocardium Ann Thorac Surg 72 2001 1950 1956
50. S. Rastogi, R.C. Gupta, S. Mishra, H. Morita, E.J. Tanhehco, and H.N. Sabbah Long-term therapy with the Acorn cardiac support device normalizes gene expression of growth factors and gelatinases in dogs with heart failure J Heart Lung Transplant 24 2005 1619 1625
51. V.G. Sharov, A.V. Todor, and H.N. Sabbah Left ventricular histomorphometric findings in dogs with heart failure treated with the Acorn Cardiac Support Device Heart Fail Rev 10 2005 141 147
52. J.N. Schroder, B. Lima, J.G. Rogers, and C.A. Milano Cardiac transplantation following ACORN CorCap device implantation Eur J Cardiothorac Surg 29 2006 848 850 Epub 2006 Apr 4
53. L. Perez de Isla, J. Zamorano, M. Quezada, C. Almería, J.L. Rodrigo, and V. Serra Prognostic significance of function mitral regurgitation after a first non-SET-segment elevation acute coronary syndrome Eur Heart J 27 2006 2655 2660
54. B. Barzilai, V.G. Davis, P.H. Stone, and A.S. Jaffe Prognostic significance of mitral regurgitation in acute myocardial infarction. The MILIS Study Group Am J Cardiol 65 1990 1169 1175
55. D.L. Ngaage, and H.V. Schaff Mitral valve surgery in non-ischemic cardiomyopathy J Cardiovasc Surg 45 2004 477